CCL2 and neoplasm: Exosomal proteoglycan profiles vary between different cancer cells11,12, supporting our finding that the same cytokine (i.e., CCL2) showed variations in its binding to exosomes from the different cancer cell lines tested, whereas different cytokines from the tumor interstitial fluid exhibited distinct levels of affinity to the same exosome.